Blaha Vladimir, Musil Frantisek, Smahelova Alena, Ticha Alena, Hyspler Radomir, Haluzik Martin, Lesna Jana, Sobotka Lubos
3rd Department of Medicine, Metabolic Care and Gerontology, Charles University in Hradec Králové, Czech Republic.
Neuro Endocrinol Lett. 2012;33 Suppl 2:6-12.
The influence of body fat reduction on adipocyte fatty acid-binding protein (A-FABP) in obese patients with type 1 diabetes mellitus (T1DM) was investigated to examine whether it relates to the etiopathogenesis of insulin resistance (IR) and obesity.
We studied 14 obese patients with T1DM and IR (42.6±9.4 years, BMI 32.4±2.1 kg/m2) and 13 non-obese control patients with T1DM (36.9±13.9 years, BMI 22.6±2.1 kg/m2). Plasma FABP was measured by ELISA and plasma free fatty acids (FFA) were measured spectrophotometrically before weight reduction, immediately after 7 days of fasting and after 21 days on a low-calorie diet. The control group was studied only after overnight fasting. Body composition was examined using bioimpedance spectroscopy. The means ± SD, T-test, one-way ANOVA and Spearman's correlation were used for statistical evaluation.
All patients tolerated the period of fasting. Obese T1DM patients lost 6.1±1.1 kg. There was a significant decrease in body mass index and body fat measured 21 days after weight reduction (p<0.05). Plasma FABP and FFA concentrations in obese T1DM patients before weight reduction were significantly higher than in controls, further increased significantly after fasting (p<0.05) and were restored thereafter. Significant positive correlations between FABP and FFA and between FABP and BMI (p<0.05) were found.
Increased plasma FABP indicates insulin resistance in obese patients with T1DM. Weight reduction in T1DM patients is associated with a desirable decrease of body fat and transiently increased FABP. This increase might be a temporary adaptation of metabolism to non-stress fasting.
研究体重减轻对 1 型糖尿病(T1DM)肥胖患者脂肪细胞脂肪酸结合蛋白(A-FABP)的影响,以探讨其是否与胰岛素抵抗(IR)和肥胖的发病机制相关。
我们研究了 14 例患有 T1DM 和 IR 的肥胖患者(42.6±9.4 岁,BMI 32.4±2.1 kg/m²)以及 13 例非肥胖的 T1DM 对照患者(36.9±13.9 岁,BMI 22.6±2.1 kg/m²)。在体重减轻前、禁食 7 天后即刻以及低热量饮食 21 天后,通过酶联免疫吸附测定法(ELISA)测量血浆 FABP,并通过分光光度法测量血浆游离脂肪酸(FFA)。对照组仅在过夜禁食后进行研究。使用生物电阻抗光谱法检查身体成分。采用均值±标准差、T 检验、单因素方差分析和 Spearman 相关性分析进行统计学评估。
所有患者均耐受禁食期。肥胖的 T1DM 患者体重减轻了 6.1±1.1 kg。体重减轻 21 天后,体重指数和体脂显著降低(p<0.05)。肥胖的 T1DM 患者体重减轻前的血浆 FABP 和 FFA 浓度显著高于对照组,禁食后进一步显著升高(p<0.05),此后恢复。发现 FABP 与 FFA 之间以及 FABP 与 BMI 之间存在显著正相关(p<0.05)。
血浆 FABP 升高表明肥胖的 T1DM 患者存在胰岛素抵抗。T1DM 患者体重减轻与体脂的理想减少以及 FABP 的短暂升高有关。这种升高可能是代谢对非应激性禁食的一种暂时适应。